Costing and Outcomes Data for Various Cancer Cohorts using Administrative Databases in Ontario
Summary
Client: Sunnybrook Research Institute
Project ID: P2017-024 / 2018 0970 108 000
Research Question/Objectives: Cancer costs in Canada are high and steadily increasing. In order to determine updated costs specific to certain cancer types, Ontario administrative data that will include utilization of publicly available health resources (e.g., hospitalizations, physician services, same day surgeries, medications, etc.) as well as outcomes (e.g., survival) will be used.
This study will investigate the outcomes and public healthcare costs of resources associated with:
- ovarian cancer with a BRCA mutation
- locally advanced non-small cell stage III lung cancer
- locally advanced or metastatic urothelial cancer
- recurrent or metastatic squamous cell carcinoma of the head and neck.
Status: Completed
Results:
- April 2022
Private Sector Project
2026
Real-world study on the effectiveness of nirmatrelvir-ritonavir in reducing severe outcomes from COVID-19
Project ID: P2023-184/ 2026 0980 010
Project Year: 2026
Status: In progress
Private Sector Project
2026
CARE: A Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
Project ID: P2024-226/ 2026 0980 009 000
Project Year: 2026
Status: In progress